RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Hyperalgesia
Accession: DOID:9002211
browse the term
Definition: An increased sensation of pain or discomfort produced by mimimally noxious stimuli due to damage to soft tissue containing NOCICEPTORS or injury to a peripheral nerve.
Synonyms: exact_synonym: Allodynia; Allodynias, Tactile; Allodynias, Thermal; Hyperalgesia, Primary; Hyperalgesia, Secondary; Hyperalgesias; Hyperalgesias, Mechanical; Hyperalgesias, Primary; Hyperalgesias, Secondary; Hyperalgesias, Tactile; Hyperalgesias, Thermal; Hyperalgesic Sensations; Mechanical Allodynia; Mechanical Allodynias; Mechanical Hyperalgesia; Tactile Allodynia; Tactile Hyperalgesia; Thermal Allodynia; Thermal Hyperalgesia; pain hypersensitivity
primary_id: MESH:D006930
G
Abat
4-aminobutyrate aminotransferase
treatment
ISO
RGD
PMID:24890317
RGD:9588557
NCBI chr16:8,331,293...8,439,432
Ensembl chr16:8,331,293...8,439,432
G
Adk
adenosine kinase
ISO
associated with diabetic neuropathies;
RGD
PMID:11423084 PMID:9932716
RGD:6482662 , RGD:6482666
NCBI chr14:21,102,622...21,498,637
Ensembl chr14:21,102,642...21,498,637
G
Adm
adrenomedullin
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17043245 PMID:17043245
RGD:1625316
NCBI chr 7:110,226,864...110,229,027
Ensembl chr 7:110,226,868...110,229,027
G
Adora1
adenosine A1 receptor
ISO
associated with Spinal Cord Injuries
RGD
PMID:20065990
RGD:5129094
NCBI chr 1:134,126,953...134,163,195
Ensembl chr 1:134,126,963...134,163,169
G
Adra1a
adrenergic receptor, alpha 1a
ISO
associated with Diabetes Mellitus, Experimental; mRNA:increased expression:dorsal root ganglion
RGD
PMID:10841349
RGD:5688377
NCBI chr14:66,872,705...67,009,549
Ensembl chr14:66,872,700...67,008,617
G
Adra2a
adrenergic receptor, alpha 2a
ISO
RGD
PMID:17959985
RGD:6480488
NCBI chr19:54,033,690...54,037,413
Ensembl chr19:54,032,582...54,037,413
G
Adra2c
adrenergic receptor, alpha 2c
ISO
RGD
PMID:20007733
RGD:6893568
NCBI chr 5:35,435,910...35,439,107
Ensembl chr 5:35,435,663...35,439,107
G
Adrb1
adrenergic receptor, beta 1
ISO
RGD
PMID:19283893
RGD:5129125
NCBI chr19:56,710,549...56,713,582
Ensembl chr19:56,710,631...56,721,545
G
Ager
advanced glycosylation end product-specific receptor
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25014009 PMID:25014009 PMID:24077211
RGD:8695980 , RGD:7364865
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9613798
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
Aif1
allograft inflammatory factor 1
ISO
associated with Alcohol-Induced Disorders, Nervous System; protein:increased expression:spinal cord (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27093858 PMID:17284346
RGD:2313035
NCBI chr17:35,389,967...35,394,977
Ensembl chr17:35,389,967...35,395,044
G
Akr1b1
aldo-keto reductase family 1 member B
ISO
associated with Hyperglycemia
RGD
PMID:12505670
RGD:1626082
NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413
G
Alox12
arachidonate 12-lipoxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12582831
NCBI chr11:70,132,283...70,146,206
Ensembl chr11:70,132,283...70,146,179
G
Alox5
arachidonate 5-lipoxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12582831
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
G
Ano3
anoctamin 3
ISO
RGD
PMID:23872594
RGD:9681745
NCBI chr 2:110,485,546...110,780,854
Ensembl chr 2:110,485,546...110,781,268
G
Anxa1
annexin A1
ISO
protein:increased expression:dorsal root ganglion
RGD
PMID:9222544 PMID:21990306
RGD:2306950 , RGD:7421656
NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308
G
Aqp4
aquaporin 4
ISO
associated with Spinal Cord Injuries;mRNA,protein:increased expression:brain,spinal cord:
RGD
PMID:16219025
RGD:8695957
NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039
G
Avp
arginine vasopressin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9613798
NCBI chr 2:130,422,540...130,424,508
Ensembl chr 2:130,422,540...130,424,474
G
Bace1
beta-site APP cleaving enzyme 1
ISO
RGD
PMID:28012171
RGD:13782150
NCBI chr 9:45,749,878...45,775,694
Ensembl chr 9:45,749,878...45,775,697
G
Bdkrb1
bradykinin receptor, beta 1
ISO IMP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17989505 PMID:19300402 PMID:19815945 PMID:12927641 PMID:12637034
RGD:1579989 , RGD:7241581
NCBI chr12:105,570,350...105,571,770
Ensembl chr12:105,569,344...105,571,687
G
Bdkrb2
bradykinin receptor, beta 2
ISO
associated with Diabetic Neuropathy CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17989505 PMID:19300402 PMID:19815945 PMID:10188975 PMID:19300402
RGD:4891040 , RGD:2313332
NCBI chr12:105,529,431...105,561,503
Ensembl chr12:105,529,485...105,561,496
G
Bdnf
brain derived neurotrophic factor
ISO IMP
associated with Peripheral Nerve Injuries; associated with Sciatic Neuropathy; associated with Pancreatitis, Chronic; associated with inflammation;protein:increased expression:dorsal root ganglion:
RGD
PMID:11425916 PMID:12470870 PMID:21499209 PMID:21864655 PMID:12435470 PMID:10779676 PMID:21958434 More...
RGD:8657088 , RGD:8657091 , RGD:8657093 , RGD:8657099 , RGD:8657101 , RGD:8657114 , RGD:8657122
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Becn1
beclin 1, autophagy related
ISO
RGD
PMID:23665054
RGD:11560531
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
G
C3
complement component 3
ISO
associated with Sciatic Neuropathy;mRNA, protein:increased expression:spinal cord
RGD
PMID:23588254
RGD:7401259
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Cacna1b
calcium channel, voltage-dependent, N type, alpha 1B subunit
ISO
RGD
PMID:17567797
RGD:1626313
NCBI chr 2:24,493,872...24,653,210
Ensembl chr 2:24,493,899...24,653,164
G
Cacna1h
calcium channel, voltage-dependent, T type, alpha 1H subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19577366 PMID:30552955 PMID:34286406
NCBI chr17:25,593,259...25,655,308
Ensembl chr17:25,593,259...25,652,759
G
Cacna1i
calcium channel, voltage-dependent, alpha 1I subunit
ISO
RGD
PMID:17112407
RGD:15003199
NCBI chr15:80,171,439...80,282,493
Ensembl chr15:80,171,439...80,282,480
G
Cacna2d1
calcium channel, voltage-dependent, alpha2/delta subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11245671 PMID:17881535 PMID:24133248
NCBI chr 5:16,139,390...16,579,509
Ensembl chr 5:16,139,786...16,579,502
G
Calca
calcitonin/calcitonin-related polypeptide, alpha
ISO
associated with inflammation;protein:increased expression:dorsal root ganglion: CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:12787826 PMID:12855330 PMID:15265675 PMID:27093858 PMID:21958434
RGD:8657122
NCBI chr 7:114,225,223...114,236,145
Ensembl chr 7:114,230,713...114,235,592
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20053885 PMID:18042863
RGD:7240711
NCBI chr18:61,058,704...61,121,224
Ensembl chr18:61,058,690...61,121,224
G
Capn2
calpain 2
treatment
ISO
associated with Peripheral Nerve Injuries
RGD
PMID:25150005
RGD:13792585
NCBI chr 1:182,294,818...182,345,175
Ensembl chr 1:182,294,825...182,345,173
G
Cartpt
CART prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21167239
NCBI chr13:100,034,991...100,037,191
Ensembl chr13:100,034,997...100,037,599
G
Cat
catalase
treatment
ISO
RGD
PMID:23952340 PMID:23658840
RGD:9479063 , RGD:9479069
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cck
cholecystokinin
ISO
RGD
PMID:15647484
RGD:1626108
NCBI chr 9:121,318,890...121,324,728
Ensembl chr 9:121,318,890...121,324,760
G
Cckbr
cholecystokinin B receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11880531 PMID:15647484
RGD:1626108
NCBI chr 7:105,075,201...105,085,546
Ensembl chr 7:105,074,938...105,120,105
G
Ccl2
C-C motif chemokine ligand 2
ISO IMP
protein:increased expression:dorsal root ganglion, spinal cord (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17881535 PMID:18419759 PMID:22531750 PMID:20737477 PMID:21712071
RGD:2307043 , RGD:8548845 , RGD:8548848 , RGD:8548873
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:dorsal root ganglion (rat)
RGD
PMID:18076762 PMID:18656466
RGD:4890034 , RGD:2303121
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Ccr2
C-C motif chemokine receptor 2
ISO IMP
associated with Bone Neoplasms;protein:increased expression:spinal cord: protein:increased expression:dorsal horn of spinal cord: associated with Sciatic Neuropathy; associated with Demyelinating Diseases; associated with Intervertebral disc disease;
RGD
PMID:18419759 PMID:23511129 PMID:22721162 PMID:24907405 PMID:18076762 PMID:24462503 More...
RGD:2307043 , RGD:8661772 , RGD:8548831 , RGD:8661781 , RGD:4890034 , RGD:8661788
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
G
Ccr5
C-C motif chemokine receptor 5
ISO IMP
mRNA:increased expression:dorsal root ganglion (rat) associated with Spinal Cord Injuries
RGD
PMID:18076762 PMID:24589480 PMID:23147416 PMID:22033364
RGD:4890034 , RGD:8551795 , RGD:8551809 , RGD:8551820
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
G
Cfl1
cofilin 1, non-muscle
ISO
protein:increased phosphorylation:dorsal root ganglion (rat)
RGD
PMID:24962708
RGD:11570412
NCBI chr19:5,540,483...5,544,059
Ensembl chr19:5,540,483...5,545,229
G
Chrna5
cholinergic receptor, nicotinic, alpha polypeptide 5
ameliorates
ISO
RGD
PMID:15652389
RGD:150530460
NCBI chr 9:54,888,112...54,918,704
Ensembl chr 9:54,888,164...54,915,063
G
Chrna7
cholinergic receptor, nicotinic, alpha polypeptide 7
ameliorates
ISO
associated with sciatic neuropathy;
RGD
PMID:20619541
RGD:151708701
NCBI chr 7:62,748,440...62,862,274
Ensembl chr 7:62,748,440...62,862,317
G
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17572696
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
G
Cnr2
cannabinoid receptor 2
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:17572696 PMID:18664590
NCBI chr 4:135,622,500...135,647,530
Ensembl chr 4:135,622,705...135,647,518
G
Comt
catechol-O-methyltransferase
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28195063 PMID:20726980
RGD:8662326
NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
G
Crcp
calcitonin gene-related peptide-receptor component protein
ISO
RGD
PMID:12895509
RGD:727768
NCBI chr 5:130,058,147...130,089,628
Ensembl chr 5:130,058,131...130,089,630
G
Crhr1
corticotropin releasing hormone receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28434951
NCBI chr11:104,021,289...104,066,349
Ensembl chr11:104,023,681...104,066,349
G
Csf3
colony stimulating factor 3 (granulocyte)
treatment
ISO
associated with Sciatic Neuropathy;
RGD
PMID:24253780
RGD:11039470
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Csk
c-src tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16769263
NCBI chr 9:57,533,929...57,560,758
Ensembl chr 9:57,533,929...57,560,914
G
Ctss
cathepsin S
ISO IMP
associated with Arthritis, Experimental associated with Colitis
RGD
PMID:22213084 PMID:21802389
RGD:5686870 , RGD:5686873
NCBI chr 3:95,434,097...95,463,716
Ensembl chr 3:95,434,097...95,463,714
G
Cx3cl1
C-X3-C motif chemokine ligand 1
treatment
ISO
associated with Arthritis, Experimental
RGD
PMID:19249394 PMID:22647647
RGD:2304251 , RGD:9491779
NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055
G
Cx3cr1
C-X3-C motif chemokine receptor 1
ISO IMP
associated with Sciatic Neuropathy associated with Bone Neoplasms associated with Inflammation associated with Arthritis, Experimental;protein:increased expression:lumbar spinal cord
RGD
PMID:19959384 PMID:20609517 PMID:20736819 PMID:20524966 PMID:16324111 PMID:22647647 More...
RGD:4891942 , RGD:4891885 , RGD:4892020 , RGD:9354422 , RGD:9387859 , RGD:9491779
NCBI chr 9:119,877,749...119,897,362
Ensembl chr 9:119,877,749...119,898,945
G
Cxcl12
C-X-C motif chemokine ligand 12
ISO
RGD
PMID:28638088
RGD:13838657
NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
G
Cxcl15
C-X-C motif chemokine ligand 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7881729 PMID:10401557
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
RGD
PMID:19283893
RGD:5129125
NCBI chr 1:74,193,153...74,200,405
Ensembl chr 1:74,193,150...74,200,405
G
Cxcr4
C-X-C motif chemokine receptor 4
treatment
ISO
RGD
PMID:28638088 PMID:30142543
RGD:13838657 , RGD:13838658
NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
G
Cybb
cytochrome b-245, beta polypeptide
IMP
associated with Spinal Cord Injuries;
RGD
PMID:20679217
RGD:11040629
NCBI chr X:9,301,493...9,354,005
Ensembl chr X:9,301,491...9,354,010
G
Dlg4
discs large MAGUK scaffold protein 4
ISO
associated with Diabetic Neuropathies:
RGD
PMID:20531396
RGD:7257680
NCBI chr11:69,908,029...69,938,107
Ensembl chr11:69,907,768...69,938,348
G
Drd3
dopamine receptor D3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20433900
NCBI chr16:43,574,285...43,646,353
Ensembl chr16:43,574,389...43,643,295
G
Dusp1
dual specificity phosphatase 1
treatment
ISO
associated with Sciatic Neuropathy
RGD
PMID:22901764 PMID:22540262
RGD:7771531 , RGD:7771574
NCBI chr17:26,724,565...26,727,446
Ensembl chr17:26,724,564...26,781,102
G
Dusp6
dual specificity phosphatase 6
treatment
ISO
associated with Sciatic Neuropathy
RGD
PMID:22901764
RGD:7771531
NCBI chr10:99,098,676...99,103,351
Ensembl chr10:99,099,093...99,103,351
G
Edn1
endothelin 1
susceptibility
IEP IMP ISO
mRNA:increased expression:paw skin (mouse) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19429182 PMID:23347081 PMID:15664691
RGD:8661716 , RGD:8661735
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
treatment
ISO
RGD
PMID:20392816
RGD:9685429
NCBI chr15:54,702,297...54,816,284
Ensembl chr15:54,702,297...54,816,288
G
Ep300
E1A binding protein p300
ISO
RGD
PMID:25263804
RGD:9588307
NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
G
Epha4
Eph receptor A4
ISO
associated with spinal cord injuries;
RGD
PMID:16959251
RGD:5688783
NCBI chr 1:77,343,819...77,491,763
Ensembl chr 1:77,343,822...77,491,725
G
Ephx2
epoxide hydrolase 2, cytoplasmic
ISO
RGD
PMID:16962614
RGD:5688387
NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949
G
Erbb4
erb-b2 receptor tyrosine kinase 4
ISO
associated with interstitial cystitis;
RGD
PMID:30989724
RGD:405295490
NCBI chr 1:68,071,063...69,147,756
Ensembl chr 1:68,071,345...69,147,218
G
Esr1
estrogen receptor 1 (alpha)
IMP
RGD
PMID:19285805
RGD:8553066
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Esr2
estrogen receptor 2 (beta)
ISO IMP
RGD
PMID:17056036 PMID:19285805
RGD:5508846 , RGD:8553066
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
G
F2
coagulation factor II
IMP
associated with Sciatic Neuropathy
RGD
PMID:16251448
RGD:7387272
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
F2r
coagulation factor II thrombin receptor
severity
IMP IDA ISO
RGD
PMID:19674841 PMID:12717003 PMID:11877315
RGD:7387269 , RGD:7387270 , RGD:7387271
NCBI chr13:95,738,288...95,754,974
Ensembl chr13:95,738,311...95,754,995
G
Fcgr1
Fc receptor, IgG, high affinity I
ameliorates
ISO
RGD
PMID:32510872
RGD:127338469
NCBI chr 3:96,190,225...96,201,285
Ensembl chr 3:96,190,225...96,201,285
G
Fos
FBJ osteosarcoma oncogene
ISO
protein:increased expression:dorsal horn of spinal cord, neuron CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27093858 PMID:22160634
RGD:9999169
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Fto
FTO alpha-ketoglutarate dependent dioxygenase
treatment
IMP
associated with Cerebral Hemorrhage
RGD
PMID:34102854
RGD:329812008
NCBI chr 8:92,039,995...92,395,061
Ensembl chr 8:92,040,153...92,395,067
G
Gad1
glutamate decarboxylase 1
treatment
ISO
protein:increased expression:dorsal horn of spinal cord
RGD
PMID:26752351 PMID:27277808
RGD:405850208 , RGD:405850240
NCBI chr 2:70,392,109...70,432,358
Ensembl chr 2:70,383,416...70,432,358
G
Gdnf
glial cell line derived neurotrophic factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20457222
NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
G
Gfap
glial fibrillary acidic protein
ISO
associated with Spinal Cord Injuries;mRNA,protein:increased expression:brain,spinal cord: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27093858 PMID:16219025
RGD:8695957
NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738
G
Gfra1
glial cell line derived neurotrophic factor family receptor alpha 1
ISO
RGD
PMID:16464682
RGD:6218969
NCBI chr19:58,224,013...58,444,387
Ensembl chr19:58,224,036...58,444,341
G
Gja1
gap junction protein, alpha 1
treatment
ISO
associated with Sciatic Neuropathy CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:34286406 PMID:24631560 PMID:23374942
RGD:8662447 , RGD:8662456
NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609
G
Gper1
G protein-coupled estrogen receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25280432
NCBI chr 5:139,408,905...139,413,555
Ensembl chr 5:139,408,906...139,413,555
G
Gria1
glutamate receptor, ionotropic, AMPA1 (alpha 1)
treatment
IEP
RGD
PMID:27816787
RGD:405650587
NCBI chr11:56,902,342...57,221,070
Ensembl chr11:56,902,213...57,221,070
G
Grin1
glutamate receptor, ionotropic, NMDA1 (zeta 1)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr 2:25,181,189...25,209,199
Ensembl chr 2:25,181,193...25,209,199
G
Grin2a
glutamate receptor, ionotropic, NMDA2A (epsilon 1)
ISO
RGD
PMID:29758384
RGD:13792698
NCBI chr16:9,385,765...9,813,744
Ensembl chr16:9,385,762...9,813,424
G
Grin2b
glutamate receptor, ionotropic, NMDA2B (epsilon 2)
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20042082 PMID:24204988
RGD:13210755
NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509
G
Grk2
G protein-coupled receptor kinase 2
treatment severity
ISO
associated with bone cancer associated with Complex Regional Pain Syndromes
RGD
PMID:26935064 PMID:26064176 PMID:25466829 PMID:22796071
RGD:13513996 , RGD:13514046 , RGD:13514049 , RGD:13792780
NCBI chr19:4,336,029...4,356,356
Ensembl chr19:4,336,029...4,356,250
G
Grm8
glutamate receptor, metabotropic 8
IDA
RGD
PMID:17113112
RGD:6771186
NCBI chr 6:27,275,120...28,135,094
Ensembl chr 6:27,275,118...28,135,177
G
Hif1a
hypoxia inducible factor 1, alpha subunit
ISO
associated with Limb Ischemia;protein:increased expression:foot muscle, plantar
RGD
PMID:18691814
RGD:9068903
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Hmgb1
high mobility group box 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27474498 PMID:24077211 PMID:30142543
RGD:7364865 , RGD:13838658
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
Hoxd1
homeobox D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21151121
NCBI chr 2:74,593,324...74,595,486
Ensembl chr 2:74,593,324...74,595,486
G
Htr2a
5-hydroxytryptamine (serotonin) receptor 2A
ISO
associated with Diabetic neuropathies; CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17888573 PMID:18930597 PMID:20531396 PMID:20039957 PMID:25584948
RGD:7257680 , RGD:401901200 , RGD:401938625
NCBI chr14:74,878,314...74,944,299
Ensembl chr14:74,878,280...74,946,934
G
Htr7
5-hydroxytryptamine (serotonin) receptor 7
ISO
RGD
PMID:21693130 PMID:21843960
RGD:6480665 , RGD:6482179
NCBI chr19:35,935,815...36,035,533
Ensembl chr19:35,936,134...36,034,907
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9452187
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Il10
interleukin 10
treatment
ISO
associated with Sciatic Neuropathy CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:7582491 PMID:17174526 PMID:23957449 PMID:22820166 PMID:24077211
RGD:7364792 , RGD:7364827 , RGD:7364865
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il13
interleukin 13
treatment
ISO
RGD
PMID:11399514
RGD:8549555
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il17a
interleukin 17A
treatment
ISO
RGD
PMID:23192794 PMID:23246025
RGD:9068942 , RGD:9222699
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il18
interleukin 18
treatment
ISO
associated with Peripheral Nerve Injuries
RGD
PMID:19036970
RGD:8655929
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12727271
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1b
interleukin 1 beta
ISO
associated with Peripheral Nerve Injuries CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:7582491 PMID:10401557 PMID:12727271 PMID:17320857 PMID:20937348 PMID:27093858 PMID:15317861 PMID:22265659 PMID:23159984 PMID:8741165 More...
RGD:1626676 , RGD:6482671 , RGD:7175548 , RGD:7401209
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1r1
interleukin 1 receptor, type I
ISO IMP
RGD
PMID:19022353 PMID:11585580
RGD:8662898 , RGD:8662903
NCBI chr 1:40,261,651...40,355,361
Ensembl chr 1:40,264,240...40,356,417
G
Il1rn
interleukin 1 receptor antagonist
treatment severity
ISO
associated with Arthritis, Experimental; rat model treated with human protein CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:8864563 PMID:15317861 PMID:17174526 PMID:20937348 PMID:23092240 PMID:22933159 PMID:17959986 PMID:10903985 More...
RGD:6909165 , RGD:6909175 , RGD:7401210 , RGD:8549800
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il2
interleukin 2
treatment
ISO
associated with Sciatic Neuropathy; mRNA,protein:increased expression:spinal cord:
RGD
PMID:12755376 PMID:22189457 PMID:18423867
RGD:8662973 , RGD:8662977 , RGD:8662980
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
G
Il33
interleukin 33
ISO
RGD
PMID:29329586
RGD:40400909
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
G
Il6
interleukin 6
ISO
associated with Foot Injuries; protein:increased expression:serum: mRNA:increased expression:dorsal root ganglion CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:7582491 PMID:10401557 PMID:18652822 PMID:18988309 PMID:23953943
RGD:8662979 , RGD:10402830
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Il6ra
interleukin 6 receptor, alpha
ISO
mRNA:increased expression:dorsal root ganglion
RGD
PMID:23953943
RGD:10402830
NCBI chr 3:89,776,631...89,820,503
Ensembl chr 3:89,771,366...89,820,503
G
Insr
insulin receptor
treatment
IEP ISO
associated with Diabetic Neuropathies CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18331706 PMID:23511693
RGD:10403050
NCBI chr 8:3,200,922...3,329,649
Ensembl chr 8:3,172,061...3,329,617
G
Itga1
integrin alpha 1
ISO
RGD
PMID:14984413 PMID:15836982
RGD:2302389 , RGD:2302139
NCBI chr13:115,094,615...115,238,500
Ensembl chr13:115,089,632...115,238,500
G
Itga2
integrin alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18234883
NCBI chr13:114,969,617...115,068,588
Ensembl chr13:114,969,617...115,068,636
G
Itga3
integrin alpha 3
ISO
RGD
PMID:15836982 PMID:14984413
RGD:2302139 , RGD:2302389
NCBI chr11:94,935,301...94,967,637
Ensembl chr11:94,935,300...94,967,627
G
Itga5
integrin alpha 5 (fibronectin receptor alpha)
ISO
RGD
PMID:14984413 PMID:15836982
RGD:2302389 , RGD:2302139
NCBI chr15:103,252,713...103,275,218
Ensembl chr15:103,252,713...103,275,190
G
Itgb1
integrin beta 1 (fibronectin receptor beta)
ISO
RGD
PMID:15836982 PMID:14984413
RGD:2302139 , RGD:2302389
NCBI chr 8:129,412,135...129,460,060
Ensembl chr 8:129,412,135...129,459,681
G
Itpr1
inositol 1,4,5-trisphosphate receptor 1
ISO
RGD
PMID:25972297
RGD:13793383
NCBI chr 6:108,190,044...108,528,077
Ensembl chr 6:108,190,057...108,528,070
G
Jak2
Janus kinase 2
treatment
ISO IMP
associated with Diabetic Neuropathies
RGD
PMID:18636982 PMID:23511693
RGD:6483031 , RGD:10403050
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
G
Jak3
Janus kinase 3
treatment
ISO
RGD
PMID:21434883
RGD:11533942
NCBI chr 8:72,129,027...72,143,221
Ensembl chr 8:72,128,940...72,143,219
G
Kcnc4
potassium voltage gated channel, Shaw-related subfamily, member 4
ISO
RGD
PMID:17855600
RGD:10411908
NCBI chr 3:107,345,614...107,367,617
Ensembl chr 3:107,345,619...107,366,868
G
Kcnk2
potassium channel, subfamily K, member 2
IMP
RGD
PMID:16675954
RGD:9831112
NCBI chr 1:188,940,127...189,134,951
Ensembl chr 1:188,940,127...189,134,470
G
Kcnq3
potassium voltage-gated channel, subfamily Q, member 3
ISO
associated with Bone Neoplasms;protein:decreased expression:dorsal root ganglia (rat)
RGD
PMID:23352759
RGD:9686417
NCBI chr15:65,858,223...66,158,485
Ensembl chr15:65,858,236...66,158,491
G
Kmo
kynurenine 3-monooxygenase
treatment
ISO
RGD
PMID:26524415
RGD:13703043
NCBI chr 1:175,459,759...175,488,419
Ensembl chr 1:175,447,947...175,489,682
G
Kng1
kininogen 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2010815 PMID:2128375 PMID:3061568 PMID:7493622 PMID:7582491 PMID:7881729 PMID:9714424 PMID:9720808 PMID:10401557 PMID:10499367 PMID:10543429 PMID:15626726 PMID:16259764 PMID:16793879 PMID:18234883 PMID:21521205 More...
NCBI chr16:22,876,970...22,900,828
Ensembl chr16:22,876,615...22,900,828
G
Kng2
kininogen 2
ISO
RGD
PMID:20868656
RGD:11059894
NCBI chr16:22,804,602...22,847,851
Ensembl chr16:22,804,604...22,848,232
G
Lepr
leptin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29143802
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
ISO
RGD
PMID:23665054
RGD:11560531
NCBI chr 2:155,118,284...155,119,993
Ensembl chr 2:155,118,217...155,119,993
G
Map2k3
mitogen-activated protein kinase kinase 3
onset
IMP
RGD
PMID:19427893
RGD:7495807
NCBI chr11:60,822,880...60,843,637
Ensembl chr11:60,822,859...60,843,637
G
Mapk1
mitogen-activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12941468 PMID:27093858
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12941468 PMID:27093858
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mapk7
mitogen-activated protein kinase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17237256
NCBI chr11:61,379,638...61,385,101
Ensembl chr11:61,379,638...61,385,232
G
Mapk8
mitogen-activated protein kinase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mapk9
mitogen-activated protein kinase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
G
Mc1r
melanocortin 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19996949
NCBI chr 8:124,133,839...124,137,483
Ensembl chr 8:124,133,846...124,137,483
G
Mc4r
melanocortin 4 receptor
ISO
protein:increased expression:dorsal root ganglia (rat)
RGD
PMID:20081244
RGD:6484233
NCBI chr18:66,990,776...66,993,558
Ensembl chr18:66,990,775...66,993,577
G
Mecp2
methyl CpG binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33010341
NCBI chr X:73,070,198...73,129,296
Ensembl chr X:73,070,198...73,129,296
G
Men1
multiple endocrine neoplasia 1
ISO
associated with Sciatic Neuropathy;protein:increased expression:spinal cord dorsal horn (rat)
RGD
PMID:20369282
RGD:9589142
NCBI chr19:6,385,009...6,390,924
Ensembl chr19:6,385,009...6,390,921
G
Mfn2
mitofusin 2
ISO
mRNA:decreased expression:spinal cord (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28587902 PMID:28587902
RGD:12910704
NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
G
Mir15b
microRNA 15b
ISO
RGD
PMID:28012171
RGD:13782150
NCBI chr 3:68,917,105...68,917,168
Ensembl chr 3:68,917,105...68,917,168
G
Mir17
microRNA 17
severity
ISO
RGD
PMID:26222740
RGD:11074685
NCBI chr14:115,281,103...115,281,186
Ensembl chr14:115,281,103...115,281,186
G
Mir381
microRNA 381
treatment
ISO
RGD
PMID:30142543
RGD:13838658
NCBI chr12:109,693,256...109,693,330
Ensembl chr12:109,693,256...109,693,330
G
Mir500
microRNA 500
ISO
RNA:decreased expression:dorsal horn of spinal cord
RGD
PMID:27277808
RGD:405850240
NCBI chr X:7,103,922...7,104,013
Ensembl chr X:7,103,922...7,104,013
G
Mir96
microRNA 96
treatment
ISO
associated with Sciatic Neuropathy
RGD
PMID:24234845
RGD:11553932
NCBI chr 6:30,169,445...30,169,550
Ensembl chr 6:30,169,445...30,169,550
G
Mmp3
matrix metallopeptidase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18754875 PMID:22056600
RGD:8693664
NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
G
Mpz
myelin protein zero
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16676325
NCBI chr 1:170,978,282...170,988,699
Ensembl chr 1:170,978,280...170,988,699
G
Mtor
mechanistic target of rapamycin kinase
ISO
RGD
PMID:24382350
RGD:10040983
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Nectin1
nectin cell adhesion molecule 1
ISO
RGD
PMID:27394444
RGD:405866373
NCBI chr 9:43,655,251...43,718,758
Ensembl chr 9:43,655,281...43,743,955
G
Nefh
neurofilament, heavy polypeptide
treatment
ISO
RGD
PMID:21071147
RGD:27226885
NCBI chr11:4,888,754...4,898,064
Ensembl chr11:4,888,754...4,898,064
G
Ngf
nerve growth factor
treatment
IMP ISO
associated with Cystitis associated with Peripheral Nerve Injuries; CTD Direct Evidence: marker/mechanism associated with Osteoarthritis, Experimental
CTD RGD
PMID:20457222 PMID:16203088 PMID:18448607 PMID:22839415 PMID:11425916 PMID:24095693 PMID:27208420 More...
RGD:7242799 , RGD:7242803 , RGD:7242849 , RGD:8657088 , RGD:402463955 , RGD:405100717
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Ngfr
nerve growth factor receptor (TNFR superfamily, member 16)
treatment
ISO
associated with Brachial Plexus Neuropathies
RGD
PMID:23324933
RGD:10413898
NCBI chr11:95,459,644...95,478,524
Ensembl chr11:95,459,644...95,478,561
G
Nlgn2
neuroligin 2
ISO
RGD
PMID:23891900
RGD:9831150
NCBI chr11:69,713,949...69,728,610
Ensembl chr11:69,713,948...69,728,610
G
Nos1
nitric oxide synthase 1, neuronal
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19300402 PMID:23909597
RGD:7257597
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
G
Nos2
nitric oxide synthase 2, inducible
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17989504 PMID:19300402
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Npy
neuropeptide Y
treatment
ISO
associated with Sciatic Neuropathy
RGD
PMID:19556004
RGD:10448929
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
G
Nrg1
neuregulin 1
ISO
associated with Sciatic Neuropathy associated with interstitial cystitis;
RGD
PMID:22212401 PMID:30989724
RGD:10449019 , RGD:405295490
NCBI chr 8:32,299,493...33,381,858
Ensembl chr 8:32,304,579...33,374,825 Ensembl chr 8:32,304,579...33,374,825
G
Ntf3
neurotrophin 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15659614
NCBI chr 6:126,078,375...126,143,703
Ensembl chr 6:126,078,375...126,143,873
G
Ntrk1
neurotrophic tyrosine kinase, receptor, type 1
ISO
RGD
PMID:17667845 PMID:20351485
RGD:5144120 , RGD:5684352
NCBI chr 3:87,685,551...87,702,549
Ensembl chr 3:87,685,551...87,702,469
G
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
IMP ISO
associated with inflammation;protein:increased expression:dorsal root ganglion:
RGD
PMID:12470870 PMID:21958434
RGD:8657091 , RGD:8657122
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
G
Ntsr1
neurotensin receptor 1
ISO
RGD
PMID:22396077
RGD:9743902
NCBI chr 2:180,141,769...180,186,772
Ensembl chr 2:180,141,769...180,186,773
G
Oprk1
opioid receptor, kappa 1
treatment
ISO
associated with Diabetes Mellitus, Experimental;
RGD
PMID:16924480
RGD:9834947
NCBI chr 1:5,658,673...5,676,357
Ensembl chr 1:5,658,689...5,676,354
G
Oprl1
opioid receptor-like 1
ISO
associated with Sciatic Neuropathy;mRNA:increased expression:spinal cord lumbar segment,dorsal root ganglion:
RGD
PMID:12106803
RGD:9835017
NCBI chr 2:181,356,585...181,362,778
Ensembl chr 2:181,356,809...181,362,778
G
Oprm1
opioid receptor, mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17996026
NCBI chr10:6,708,593...6,988,209
Ensembl chr10:6,708,506...6,988,198
G
P2rx2
purinergic receptor P2X, ligand-gated ion channel, 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19383439
NCBI chr 5:110,487,678...110,491,186
Ensembl chr 5:110,487,678...110,491,078
G
P2rx3
purinergic receptor P2X, ligand-gated ion channel, 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19383439
NCBI chr 2:84,826,893...84,867,446
Ensembl chr 2:84,828,927...84,867,806
G
P2rx4
purinergic receptor P2X, ligand-gated ion channel 4
treatment
ISO
associated with Peripheral Nerve Injuries;
RGD
PMID:29927790
RGD:40924654
NCBI chr 5:122,845,581...122,867,802
Ensembl chr 5:122,845,607...122,867,801
G
P2ry12
purinergic receptor P2Y, G-protein coupled 12
IDA ISO
RGD
PMID:20398327 PMID:20136836
RGD:6480525 , RGD:6480526
NCBI chr 3:59,123,692...59,170,408
Ensembl chr 3:59,123,693...59,170,292
G
Pawr
PRKC, apoptosis, WT1, regulator
treatment
ISO
RGD
PMID:17179954
RGD:9835416
NCBI chr10:108,168,050...108,250,708
Ensembl chr10:108,167,982...108,250,101
G
Pdyn
prodynorphin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17670969
NCBI chr 2:129,528,469...129,541,858
Ensembl chr 2:129,528,485...129,541,764
G
Penk
preproenkephalin
treatment
ISO
associated with Diabetes Mellitus, Experimental;
RGD
PMID:23235561
RGD:10003116
NCBI chr 4:4,133,536...4,138,815
Ensembl chr 4:4,133,531...4,138,819
G
Pla2g4a
phospholipase A2, group IVA (cytosolic, calcium-dependent)
ISO
RGD
PMID:16203828
RGD:1642461
NCBI chr 1:149,705,369...149,837,041
Ensembl chr 1:149,705,369...149,837,041
G
Pnoc
prepronociceptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12665541 PMID:19231294
NCBI chr14:65,638,931...65,662,908
Ensembl chr14:65,638,122...65,662,921
G
Ppp2ca
protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform
ISO
RGD
PMID:26732138
RGD:11572421
NCBI chr11:51,989,651...52,013,576
Ensembl chr11:51,989,508...52,018,605
G
Prkcb
protein kinase C, beta
ISO
associated with inflammation;protein:increased activity:spinal cord
RGD
PMID:16360284
RGD:1625519
NCBI chr 7:121,888,327...122,233,625
Ensembl chr 7:121,887,974...122,233,625
G
Prkce
protein kinase C, epsilon
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11738263 PMID:12582831 PMID:20457222
NCBI chr17:86,472,631...86,965,347
Ensembl chr17:86,475,213...86,965,347
G
Prkcg
protein kinase C, gamma
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19955894 PMID:27093858 PMID:12560106
RGD:28867224
NCBI chr 7:3,352,038...3,379,615
Ensembl chr 7:3,337,704...3,379,615
G
Prkcz
protein kinase C, zeta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27899695
NCBI chr 4:155,344,579...155,445,856
Ensembl chr 4:155,344,586...155,445,818
G
Prkg1
protein kinase, cGMP-dependent, type I
treatment
IMP
RGD
PMID:14973199
RGD:7775058
NCBI chr19:30,541,887...31,742,675
Ensembl chr19:30,541,889...31,742,433
G
Prok2
prokineticin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16793879
NCBI chr 6:99,687,833...99,703,368
Ensembl chr 6:99,688,260...99,703,353
G
Prokr1
prokineticin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16793879
NCBI chr 6:87,555,568...87,567,741
Ensembl chr 6:87,555,573...87,567,725
G
Ptafr
platelet-activating factor receptor
treatment
ISO
RGD
PMID:16925995
RGD:10041052
NCBI chr 4:132,291,378...132,309,994
Ensembl chr 4:132,291,378...132,309,994
G
Ptger1
prostaglandin E receptor 1 (subtype EP1)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11375261
NCBI chr 8:84,393,171...84,399,385
Ensembl chr 8:84,393,307...84,399,382
G
Ptger3
prostaglandin E receptor 3 (subtype EP3)
ISO
protein:increased expression:lumbar spinal cord dorsal horn (rat)
RGD
PMID:17413918
RGD:5688169
NCBI chr 3:157,272,459...157,350,392
Ensembl chr 3:157,272,529...157,351,525
G
Ptger4
prostaglandin E receptor 4 (subtype EP4)
treatment
ISO
RGD
PMID:20423341
RGD:10003041
NCBI chr15:5,262,880...5,273,668
Ensembl chr15:5,236,142...5,273,668
G
Ptges3
prostaglandin E synthase 3
ISO
RGD
PMID:16192391
RGD:5688057
NCBI chr10:127,894,851...127,913,123
Ensembl chr10:127,894,823...127,913,141
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:spinal cord CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17989504 PMID:17413918
RGD:5688169
NCBI chr 2:36,106,758...36,142,287
Ensembl chr 2:36,120,438...36,142,284
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17112505 PMID:17989504 PMID:15464832
RGD:5688224
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Pthlh
parathyroid hormone-like peptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16769263
NCBI chr 6:147,153,607...147,165,511
Ensembl chr 6:147,153,599...147,165,681
G
Raf1
v-raf-leukemia viral oncogene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18976650
NCBI chr 6:115,595,530...115,653,596
Ensembl chr 6:115,595,028...115,653,596
G
Rgs4
regulator of G-protein signaling 4
treatment
ISO
associated with lesion of sciatic nerve
RGD
PMID:27641322
RGD:13524513
NCBI chr 1:169,569,046...169,575,211
Ensembl chr 1:169,569,046...169,575,211
G
Scn10a
sodium channel, voltage-gated, type X, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16545521 PMID:19070548
RGD:6484253
NCBI chr 9:119,437,522...119,548,388
Ensembl chr 9:119,437,522...119,548,388
G
Scn11a
sodium channel, voltage-gated, type XI, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23264124
NCBI chr 9:119,582,829...119,654,522
Ensembl chr 9:119,582,825...119,654,522
G
Sin3a
transcriptional regulator, SIN3A (yeast)
ISO
associated with Arthritis, Experimental;mRNA:decreased expression:spinal cord, neuron
RGD
PMID:17553988
RGD:9495916
NCBI chr 9:56,979,271...57,035,652
Ensembl chr 9:56,979,324...57,035,650
G
Slc12a5
solute carrier family 12, member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20086212
NCBI chr 2:164,802,766...164,841,651
Ensembl chr 2:164,802,722...164,841,651
G
Slc17a8
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8
ISO
protein:increased expression:dorsal horn of spinal cord, neuron
RGD
PMID:22160634
RGD:9999169
NCBI chr10:89,409,882...89,457,111
Ensembl chr10:89,409,882...89,457,115
G
Sparc
secreted acidic cysteine rich glycoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20714283
NCBI chr11:55,284,985...55,310,906
Ensembl chr11:55,285,326...55,314,009
G
Src
Rous sarcoma oncogene
ISO
protein:increased phosphorylation:spinal cord
RGD
PMID:27394444
RGD:405866373
NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782
G
Stat3
signal transducer and activator of transcription 3
treatment
ISO
RGD
PMID:24098399
RGD:8694290
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
G
Syn2
synapsin II
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18701217
NCBI chr 6:115,111,863...115,259,587
Ensembl chr 6:115,111,863...115,258,967
G
Tac1
tachykinin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8864563 PMID:9714424 PMID:10499367 PMID:12351280 PMID:12787826 PMID:15626726 PMID:16259764 PMID:18234883 PMID:19231294 More...
NCBI chr 6:7,555,061...7,562,978
Ensembl chr 6:7,554,879...7,565,834
G
Tacr1
tachykinin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15964684 PMID:17123731
NCBI chr 6:82,378,990...82,537,085
Ensembl chr 6:82,379,315...82,537,085
G
Tcf7l2
transcription factor 7 like 2, T cell specific, HMG box
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33607128
NCBI chr19:55,730,227...55,922,091
Ensembl chr19:55,730,252...55,922,086
G
Tgfbr1
transforming growth factor, beta receptor I
ISO
associated with Experimental Pancreatitis, Chronic
RGD
PMID:26645248
RGD:14995470
NCBI chr 4:47,353,258...47,414,926
Ensembl chr 4:47,353,222...47,414,931
G
Thbd
thrombomodulin
treatment
ISO
associated with Inflammation CTD Direct Evidence: therapeutic
CTD RGD
PMID:27474498 PMID:24004409
RGD:11038687
NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
G
Tlr2
toll-like receptor 2
IMP ISO
RGD
PMID:17355971 PMID:24204973
RGD:8553059 , RGD:8553185
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr4
toll-like receptor 4
ISO IMP
RGD
PMID:20714435 PMID:15809417 PMID:24204973
RGD:4144070 , RGD:7815040 , RGD:8553185
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tnf
tumor necrosis factor
ISO IEP IMP
protein:increased expression:lumbar vertebra: mRNA,protein:increased expression:spinal cord: associated with Diabetic Neuropathies; CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:7582491 PMID:7881729 PMID:10401557 PMID:12727271 PMID:16472913 PMID:17320857 PMID:18463260 PMID:18582539 PMID:20383154 PMID:26141506 PMID:27093858 PMID:16675114 PMID:17459378 PMID:18790011 PMID:18790011 PMID:10825476 PMID:17304130 PMID:21104419 More...
RGD:7387300 , RGD:7387302 , RGD:7394737 , RGD:7394737 , RGD:7394741 , RGD:7394757 , RGD:7401179
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf11b
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16769263
NCBI chr15:54,114,014...54,141,700
Ensembl chr15:54,114,015...54,141,880
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
treatment
ISO IMP
associated with Sciatic Neuropathy
RGD
PMID:12752784 PMID:21145890 PMID:20417692 PMID:24257399 PMID:21712071 PMID:22652595 More...
RGD:5130913 , RGD:5130939 , RGD:8661726 , RGD:8661737 , RGD:8548873 , RGD:8661750
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Tnfrsf1b
tumor necrosis factor receptor superfamily, member 1b
IMP ISO
associated with Sciatic Neuropathy
RGD
PMID:18463260 PMID:22652595
RGD:5130960 , RGD:8661750
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
ISO
associated with Peripheral Nerve Injuries; CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18234885 PMID:21481532 PMID:23523557 PMID:18954467
RGD:10043618
NCBI chr 1:14,942,868...14,989,086
Ensembl chr 1:14,942,872...14,989,086
G
Trpc1
transient receptor potential cation channel, subfamily C, member 1
ISO
associated with Inflammation
RGD
PMID:19439599
RGD:7247605
NCBI chr 9:95,587,125...95,632,438
Ensembl chr 9:95,587,135...95,632,428
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
ISO
RGD
PMID:19439599
RGD:7247605
NCBI chr 9:8,543,868...8,680,753
Ensembl chr 9:8,544,143...8,680,742
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
ISO
associated with inflammation;protein:increased expression:dorsal root ganglion: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12151517 PMID:18234885 PMID:18774343 PMID:23006841 PMID:21958434
RGD:8657122
NCBI chr11:73,124,975...73,152,148
Ensembl chr11:73,125,118...73,152,068
G
Trpv4
transient receptor potential cation channel, subfamily V, member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18234883
NCBI chr 5:114,760,213...114,796,497
Ensembl chr 5:114,760,213...114,796,482
G
Vip
vasoactive intestinal polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12787826
NCBI chr10:5,589,131...5,597,617
Ensembl chr10:5,589,218...5,597,617
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all